|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Zyrtec (cetirizine hydrochloride) Tablets, 5 and 10 mg, and Syrup, 1mg/ml, Pfizer NDA 19-835/S-015 & 20-346/S-008 10/21/02 10/28/02 10/25/02 Zyrtec (cetirizine HCl) Tablets Pfizer NDA 19-835/S-005 5/15/98 5/15/98 5/22/01 Zyrtec (cetirizine HCl) Syrup Pfizer NDA 20-346/S-002 5/15/98 5/15/98 5/22/01 Zyrtec Indication: These supplements provide for the use of Zyrtec in pediatric patients 2 to 5 years of age for the indications seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. Zyrtec-D 12 hr. Extended-Release Tablets (Cetirizine Hydrochloride & Pseudoephedrine Hydrochloride), Pfizer NDA 21-150/S2 4/14/03 4/18/03 Zyrtec-D 12 hr. Extended-Release Tablets (Cetirizine Hydrochloride & Pseudoephedrine Hydrochloride), 5 mg & 120 mg, Pfizer NDA 21-150 8/10/01 8/14/01 11/6/01 2/28/02 Zyrtec Indication: For the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis in adults and children 12 years of age and older. Zyrtec (cetirizine HCl) Tablets, Pfizer Zyrtec (cetirizine hydrochloride) Tablets, Syrup & Extended-Release Tablets, Pfizer Cetirizine Hydrochloride Tablets, Mylan Pharmaceuticals, Tentative Approval | Cetirizine Hydrochloride Tablets, Teva Pharma, Tentative Approval | Zyrtec (cetirizine HCl) Tablets, Pfizer, Formulation Revision | Cetirizine Hydrochloride Syrup, Ranbaxy Labs, Tentative Approval | Cetirizine Hydrochloride Syrup, Taro Pharma, Tentative Approval
|